BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

694 related articles for article (PubMed ID: 24413734)

  • 1. Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas.
    Palomero T; Couronné L; Khiabanian H; Kim MY; Ambesi-Impiombato A; Perez-Garcia A; Carpenter Z; Abate F; Allegretta M; Haydu JE; Jiang X; Lossos IS; Nicolas C; Balbin M; Bastard C; Bhagat G; Piris MA; Campo E; Bernard OA; Rabadan R; Ferrando AA
    Nat Genet; 2014 Feb; 46(2):166-70. PubMed ID: 24413734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic RHOA mutation in angioimmunoblastic T cell lymphoma.
    Sakata-Yanagimoto M; Enami T; Yoshida K; Shiraishi Y; Ishii R; Miyake Y; Muto H; Tsuyama N; Sato-Otsubo A; Okuno Y; Sakata S; Kamada Y; Nakamoto-Matsubara R; Tran NB; Izutsu K; Sato Y; Ohta Y; Furuta J; Shimizu S; Komeno T; Sato Y; Ito T; Noguchi M; Noguchi E; Sanada M; Chiba K; Tanaka H; Suzukawa K; Nanmoku T; Hasegawa Y; Nureki O; Miyano S; Nakamura N; Takeuchi K; Ogawa S; Chiba S
    Nat Genet; 2014 Feb; 46(2):171-5. PubMed ID: 24413737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of the biologic and clinical significance of genetic mutations in angioimmunoblastic T-cell lymphoma.
    Fukumoto K; Nguyen TB; Chiba S; Sakata-Yanagimoto M
    Cancer Sci; 2018 Mar; 109(3):490-496. PubMed ID: 28889481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angioimmunoblastic T cell lymphoma: novel molecular insights by mutation profiling.
    Wang M; Zhang S; Chuang SS; Ashton-Key M; Ochoa E; Bolli N; Vassiliou G; Gao Z; Du MQ
    Oncotarget; 2017 Mar; 8(11):17763-17770. PubMed ID: 28148900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Survey of Somatic Mutations in 41 Genes in a Cohort of T-Cell Lymphomas Identifies Frequent Mutations in Genes Involved in Epigenetic Modification.
    Fernandez-Pol S; Ma L; Joshi RP; Arber DA
    Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):416-422. PubMed ID: 29629950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of the circulating tumor DNAs in angioimmunoblastic T- cell lymphoma.
    Sakata-Yanagimoto M; Nakamoto-Matsubara R; Komori D; Nguyen TB; Hattori K; Nanmoku T; Kato T; Kurita N; Yokoyama Y; Obara N; Hasegawa Y; Shinagawa A; Chiba S
    Ann Hematol; 2017 Sep; 96(9):1471-1475. PubMed ID: 28634614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recurrent mutations in RHOA and FYN in peripheral T cell lymphomas].
    Couronné L; Bastard C; Bernard OA
    Med Sci (Paris); 2014 May; 30(5):488-92. PubMed ID: 24939529
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinicopathological Implications of RHOA Mutations in Angioimmunoblastic T-Cell Lymphoma: A Meta-analysis: RHOA mutations in AITL.
    Nguyen PN; Tran NTB; Nguyen TPX; Ngo TNM; Lai DV; Deel CD; Hassell LA; Vuong HG
    Clin Lymphoma Myeloma Leuk; 2021 Jul; 21(7):431-438. PubMed ID: 33849798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative clinicopathological and molecular analyses of angioimmunoblastic T-cell lymphoma and other nodal lymphomas of follicular helper T-cell origin.
    Dobay MP; Lemonnier F; Missiaglia E; Bastard C; Vallois D; Jais JP; Scourzic L; Dupuy A; Fataccioli V; Pujals A; Parrens M; Le Bras F; Rousset T; Picquenot JM; Martin N; Haioun C; Delarue R; Bernard OA; Delorenzi M; de Leval L; Gaulard P
    Haematologica; 2017 Apr; 102(4):e148-e151. PubMed ID: 28082343
    [No Abstract]   [Full Text] [Related]  

  • 10. A recurrent inactivating mutation in RHOA GTPase in angioimmunoblastic T cell lymphoma.
    Yoo HY; Sung MK; Lee SH; Kim S; Lee H; Park S; Kim SC; Lee B; Rho K; Lee JE; Cho KH; Kim W; Ju H; Kim J; Kim SJ; Kim WS; Lee S; Ko YH
    Nat Genet; 2014 Apr; 46(4):371-5. PubMed ID: 24584070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of the G17V RHOA mutation in angioimmunoblastic T-cell lymphoma and related lymphomas using quantitative allele-specific PCR.
    Nakamoto-Matsubara R; Sakata-Yanagimoto M; Enami T; Yoshida K; Yanagimoto S; Shiozawa Y; Nanmoku T; Satomi K; Muto H; Obara N; Kato T; Kurita N; Yokoyama Y; Izutsu K; Ota Y; Sanada M; Shimizu S; Komeno T; Sato Y; Ito T; Kitabayashi I; Takeuchi K; Nakamura N; Ogawa S; Chiba S
    PLoS One; 2014; 9(10):e109714. PubMed ID: 25310466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive analysis of RHOA mutation positive and negative angioimmunoblastic T-cell lymphomas by targeted deep sequencing, expression profiling and single cell digital image analysis.
    Butzmann A; Sridhar K; Jangam D; Kumar J; Sahoo MK; Shahmarvand N; Warnke R; Rangasamy E; Pinsky BA; Ohgami RS
    Int J Mol Med; 2020 Oct; 46(4):1466-1476. PubMed ID: 32945366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathological features of angioimmunoblastic T-cell lymphomas with IDH2
    Steinhilber J; Mederake M; Bonzheim I; Serinsöz-Linke E; Müller I; Fallier-Becker P; Lemonnier F; Gaulard P; Fend F; Quintanilla-Martinez L
    Mod Pathol; 2019 Jul; 32(8):1123-1134. PubMed ID: 30952970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCL6 locus is hypermethylated in angioimmunoblastic T-cell lymphoma.
    Nishizawa S; Sakata-Yanagimoto M; Hattori K; Muto H; Nguyen T; Izutsu K; Yoshida K; Ogawa S; Nakamura N; Chiba S
    Int J Hematol; 2017 Apr; 105(4):465-469. PubMed ID: 27921272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent TET2 mutations in peripheral T-cell lymphomas correlate with TFH-like features and adverse clinical parameters.
    Lemonnier F; Couronné L; Parrens M; Jaïs JP; Travert M; Lamant L; Tournillac O; Rousset T; Fabiani B; Cairns RA; Mak T; Bastard C; Bernard OA; de Leval L; Gaulard P
    Blood; 2012 Aug; 120(7):1466-9. PubMed ID: 22760778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The new biology of PTCL-NOS and AITL: current status and future clinical impact.
    Timmins MA; Wagner SD; Ahearne MJ
    Br J Haematol; 2020 Apr; 189(1):54-66. PubMed ID: 32064593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Droplet digital polymerase chain reaction assay and peptide nucleic acid-locked nucleic acid clamp method for RHOA mutation detection in angioimmunoblastic T-cell lymphoma.
    Tanzima Nuhat S; Sakata-Yanagimoto M; Komori D; Hattori K; Suehara Y; Fukumoto K; Fujisawa M; Kusakabe M; Matsue K; Wakamatsu H; Shimadzu M; Chiba S
    Cancer Sci; 2018 May; 109(5):1682-1689. PubMed ID: 29493850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multistep tumorigenesis in peripheral T cell lymphoma.
    Sakata-Yanagimoto M
    Int J Hematol; 2015 Nov; 102(5):523-7. PubMed ID: 25628103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusion transcripts FYN-TRAF3IP2 and KHDRBS1-LCK hijack T cell receptor signaling in peripheral T-cell lymphoma, not otherwise specified.
    Debackere K; Marcelis L; Demeyer S; Vanden Bempt M; Mentens N; Gielen O; Jacobs K; Broux M; Verhoef G; Michaux L; Graux C; Wlodarska I; Gaulard P; de Leval L; Tousseyn T; Cools J; Dierickx D
    Nat Commun; 2021 Jun; 12(1):3705. PubMed ID: 34140493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell.
    Yao WQ; Wu F; Zhang W; Chuang SS; Thompson JS; Chen Z; Zhang SW; Clipson A; Wang M; Liu H; Bibawi H; Huang Y; Campos L; Grant JW; Wright P; Ei-Daly H; Rásó-Barnett L; Farkas L; Follows GA; Gao Z; Attygalle AD; Ashton-Key M; Liu W; Du MQ
    J Pathol; 2020 Mar; 250(3):346-357. PubMed ID: 31859368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.